This trial is recruiting individuals with acute cervical (neck area) spinal cord injuries to test the safety and effect of an experimental drug (MT-3921). Earlier studies have shown that the drug may protect nerves, reduce inflammation and promote regeneration. Participants will be randomized to either receive the MT-3921 drug injected into a vein or a placebo (inactive) drug. Final testing (i.e., arm and hand function tests) will be performed 6 months after the start of the intervention.
Traumatic
Type
Details
The participant will be randomized (2:1) to either receive 1) the MT-3921 drug injected into a vein or 2) a placebo drug. Frequency and total number of injections is not provided. Further information needs to be acquired directly from the investigator.” Final testing (i.e., arm and hand function tests and activities of daily living)) will be performed 6 months after the start of the intervention.
Main benefits
Arm/hand function
Additional benefits
General health
Sensory function
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more